Unknown

Dataset Information

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.


ABSTRACT:

Introduction

Small-scale clinical studies with psychedelic drugs have shown promising results for the treatment of several mental disorders. Before psychedelics become registered medicines, it is important to know the full range of adverse events (AEs) for making balanced treatment decisions.

Objective

To systematically review the presence of AEs during and after administration of serotonergic psychedelics and 3,4-methyenedioxymethamphetamine (MDMA) in clinical studies.

Methods

We systematically searched PubMed, PsycINFO, Embase, and ClinicalTrials.gov for clinical trials with psychedelics since 2000 describing the results of quantitative and qualitative studies.

Results

We included 44 articles (34 quantitative + 10 qualitative), describing treatments with MDMA

SUBMITTER: Breeksema JJ 

PROVIDER: S-EPMC9548934 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature